SOLCOSERYL

2,125MG/G+10MG/G ORM PST 1X5G

SÚKL code 0136395
Name of the product SOLCOSERYL
_MA_MEDICATION_DETAIL_INFO_MED_NAME i SOLCOSERYL
Supplement 2,125MG/G+10MG/G ORM PST 1X5G
Strenght 2,125MG/G+10MG/G
Pharmaceutical form Oromucosal paste
Package 1X5G
Route Oromucosal use
Wrap type Tube
Legal status OTC medicinal products
Active substance DEPROTEINATED CALF BLOOD (VITULINAE SANGUINIS FRACTIO DEPROTEINATA)
LAUROMACROGOL 450 (LAUROMACROGOLUM 450)
ATC group A01AD11
ATC group name RŮZNÁ JINÁ LÉČIVA PRO LOKÁLNÍ LÉČBU V DUTINĚ ÚSTNÍ

Marketing authorisation information

Registration Number 95/ 101/85-C
Type of MA National
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 28. 02. 2019
MA Holder MEDA Pharma s.r.o., Praha
MA Holder country ČESKÁ REPUBLIKA
Actual MA holder Mylan IRE Healthcare Limited, Dublin
Actual MA holder country IRSKO

Back to list